EV/EBITDA
-1.36
+0.05+3.55%
10 min ago
Summary
- As of February 7, 2025, ALLO EV/EBITDA is -1.36, with a rise of +0.05 (+3.55%) during the most recent trading day.
- Over the past year, ALLO EV/EBITDA has increased by +0.93 (+40.61%).
- ALLO EV/EBITDA is now -4.62% below its all-time high of -1.30.
Performance
ALLO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ALLO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.5% | -3.7% | -4.1% |
| 1 m1 month | +33.3% | -33.3% | -35.5% |
| 3 m3 months | +49.1% | -48.9% | -51.4% |
| 6 m6 months | +17.6% | -16.2% | -36.8% |
| ytdytd | +24.4% | -24.4% | -26.2% |
| 1 y1 year | +40.6% | -48.3% | -61.7% |
| 5 y5 years | +90.5% | -87.4% | -93.5% |
ALLO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -2.04 | +33.3% | |
| 3 m | 3-month | -1.36 | at high | -2.74 | +50.4% |
| 6 m | 6-month | -1.36 | at high | -2.74 | +50.4% |
| 1 y | 1-year | -1.36 | at high | -3.20 | +57.5% |
| 3 y | 3-year | -1.30 | -4.6% | -11.19 | +87.8% |
| 5 y | 5-year | -1.30 | -4.6% | -30.84 | +95.6% |
| alltime | all time | -1.30 | -4.6% | -30.84 | +95.6% |
Allogene Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.36(-24.4%) |
| 2024 | -1.80(-3.2%) |
| 2023 | -1.86(-37.2%) |
| 2022 | -2.96(-75.2%) |
| Date | Value |
|---|---|
| 2021 | -11.95(-12.3%) |
| 2020 | -13.62(-13.6%) |
| 2019 | -15.77(+1.5%) |
| 2018 | -15.53 |
FAQ
- What is Allogene Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Allogene Therapeutics?
- What is ALLO EV/EBITDA year-to-date change?
- What is Allogene Therapeutics EV/EBITDA year-on-year change?
What is Allogene Therapeutics EV/EBITDA?
The current EV/EBITDA of ALLO is -1.36
What is the all time high EV/EBITDA for Allogene Therapeutics?
Allogene Therapeutics all-time high EV/EBITDA is -1.30
What is ALLO EV/EBITDA year-to-date change?
Allogene Therapeutics EV/EBITDA has changed by +0.44 (+24.44%) since the beginning of the year
What is Allogene Therapeutics EV/EBITDA year-on-year change?
Over the past year, ALLO EV/EBITDA has changed by +0.93 (+40.61%)